Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency ; volume:45 ; number:1 ; day:12 ; month:9 ; year:2024 ; pages:1-4 ; date:12.2025
Journal of clinical immunology ; 45, Heft 1 (12.9.2024), 1-4, 12.2025

Classification: Medizin, Gesundheit

Creator: Toskov, Vasil
Bali, Pawan
Hershfield, Michael S.
Ehl, Stephan
Speckmann, Carsten

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10875-024-01794-7

URN: urn:nbn:de:101:1-2411262110218.169564088055

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Toskov, Vasil
Bali, Pawan
Hershfield, Michael S.
Ehl, Stephan
Speckmann, Carsten
SpringerLink (Online service)

Other Objects (12)

Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype

Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors

Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes

Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype

Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors

Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes

Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype

Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors

Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype

Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors

Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes

Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype

Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors

Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes

Successful long-term enzyme replacement therapy in a patient with delayed-onset ADA deficiency

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox

Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype

Disease pathophysiology in murine models of primary hemophagocytic lymphohistiocytosis: triggers and effectors

Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Tracing the specificity of CRISPR-Cas nucleases in clinically relevant human cells

Cell versus cytokine – directed therapies for hemophagocytic lymphohistiocytosis (HLH) in inborn errors of immunity

Immunomodulatory effects of different Cannabis extracts on human primary lymphocytes

Related objects

Reset password